Migraine trials in Portugal
6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- Where
- Almada, Coimbra, Porto
- Age
- 12 years to 17 years
- People
- 285 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT04965675 · EU 2024-510656-13-00 - Phase 3Taking peopleA Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Where
- Almada, Braga, Coimbra, Lisbon, Porto
- Age
- 6 years to 17 years
- People
- 600 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05164172 · EU 2022-502917-27-00 - Phase 3Taking peopleA Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- Where
- Braga, Coimbra, Lisbon, Porto
- Age
- 6 years to 17 years
- People
- 315 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05897320 · EU 2022-502538-14-00 - Phase 3Taking peopleA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Where
- Almada, Coimbra, Lisbon, Porto
- Age
- 12 years to 17 years
- People
- 420 worldwide
- Run by
- AbbVie
See details and how to joinNCT06810505 · EU 2024-513836-28-00 - No phaseTaking peopleReal-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- Where
- Lisbon
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07159750 - Phase 3Enrolling by invitationLong-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Almada, Coimbra, Lisbon, Porto
- Age
- 6 years to 17 years
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00